Evidence-grade · Registered-dietitian reviewed · No sponsored placements Methodology · Editorial standards

Dr. Hilda Östberg, MD, MPH

Medical Reviewer

Eleven years in clinical practice; four years in editorial medical review

About Dr. Hilda Östberg

Hilda Östberg is the medical reviewer for Nutrient Metrics. Every clinical claim that appears anywhere on the site — that a particular protein intake range is appropriate for a particular age band, that a particular nutrient deficiency is plausible in a particular dietary pattern, that a particular drug class interacts with a particular nutritional recommendation — passes through her sign-off before publication.

She trained at Karolinska Institute, completed her clinical specialization in internal medicine, and added a board certification in preventive medicine after an MPH at Johns Hopkins Bloomberg School of Public Health. Her clinical interest has long been the cardiometabolic patient population: type 2 diabetes, metabolic syndrome, the early treatment phase of obesity pharmacotherapy. The growth of GLP-1 receptor agonists in primary care has put a much greater proportion of her practice into the territory where nutrition app data, clinician guidance, and pharmacology have to be reconciled in the same office visit. That intersection is most of what she reviews on Nutrient Metrics.

She has reviewed clinical content for European medical publications since 2021, and she joined Nutrient Metrics as medical reviewer in September 2025. Her standard is the standard she uses for the medical literature she reviews: a claim is acceptable if it is supported by named, citable evidence at a defensible strength, and unacceptable if the evidence is absent or contradicted. She rewrites claims rather than passing them when the underlying evidence is weaker than the published wording would suggest.

Credentials in detail

Editorial focus

Dr. Östberg reviews every clinical claim before publication on Nutrient Metrics. She owns the medical-disclaimer language, the eating-disorder-resource policy, and the GLP-1-related editorial guidance. She co-signs every evidence brief that summarizes a clinical paper.

Conflicts of interest

Dr. Östberg declares no financial relationships with the manufacturers of GLP-1 receptor agonists or any other pharmaceutical product, no equity positions in nutrition app developers, and no affiliate relationships with any product evaluated on Nutrient Metrics. Her clinical practice is unaffiliated with any of the products discussed in her reviews here.

Recent work

Guides

Evidence briefs

Protein

Micronutrients

Hypertrophy